BIOMAT Database Logo BIOMAT Database Logo

Prostaglandin E1 in obstructive peripheral vascular disease. 1983

N A Fernandez, and V Rosenberg, and M Lee, and A Singer

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D005260 Female Females
D005528 Foot The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones. Feet
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D013919 Thromboangiitis Obliterans A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking. Buerger Disease,Buerger's Disease,Thromboangitis Obliterans,Buergers Disease,Disease, Buerger,Disease, Buerger's

Related Publications

N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Intravenous prostaglandin E1 in severe peripheral vascular disease.
October 1976, Lancet (London, England),
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
October 2001, American heart journal,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
December 1982, The Journal of the Medical Society of New Jersey,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Treatment of complications of peripheral obstructive arterial disease with prostaglandin E1.
July 1987, Angiology,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Prostaglandin E1 therapy for peripheral vascular disease is better than placebo.
April 1982, Clinical physiology (Oxford, England),
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
November 2002, Prostaglandins, leukotrienes, and essential fatty acids,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease.
March 1990, Lancet (London, England),
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
April 1998, Scandinavian journal of clinical and laboratory investigation,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
February 2003, American heart journal,
N A Fernandez, and V Rosenberg, and M Lee, and A Singer
[Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
January 1991, Wiener klinische Wochenschrift,
Copied contents to your clipboard!